{
  "fields_data": [
    {
      "subheading": "General Request Information",
      "fields": [
        {
          "name": "Treatment Status",
          "type": "radio_choice",
          "options": [
            {
              "name": "Start of treatment",
              "sub_fields": [
                {
                  "name": "Start date",
                  "type": "date",
                  "format": "MM/DD/YYYY"
                }
              ]
            },
            {
              "name": "Continuation of therapy",
              "sub_fields": [
                {
                  "name": "Date of last treatment",
                  "type": "date",
                  "format": "MM/DD/YYYY"
                }
              ]
            }
          ]
        },
        {
          "name": "Precertification Requested By",
          "type": "string"
        },
        {
          "name": "Precertification Request Phone",
          "type": "string"
        },
        {
          "name": "Precertification Request Fax",
          "type": "string"
        }
      ]
    },
    {
      "subheading": "Patient Information",
      "fields": [
        {
          "name": "First Name",
          "type": "string"
        },
        {
          "name": "Last Name",
          "type": "string"
        },
        {
          "name": "DOB",
          "type": "date",
          "format": "MM/DD/YYYY"
        },
        {
          "name": "Address",
          "type": "string"
        },
        {
          "name": "City",
          "type": "string"
        },
        {
          "name": "State",
          "type": "string"
        },
        {
          "name": "ZIP",
          "type": "string"
        },
        {
          "name": "Home Phone",
          "type": "string"
        },
        {
          "name": "Work Phone",
          "type": "string"
        },
        {
          "name": "Cell Phone",
          "type": "string"
        },
        {
          "name": "E-mail",
          "type": "string"
        },
        {
          "name": "Current Weight",
          "type": "number_with_units",
          "unit_options": [
            "lbs",
            "kgs"
          ]
        },
        {
          "name": "Height",
          "type": "number_with_units",
          "unit_options": [
            "inches",
            "cms"
          ]
        },
        {
          "name": "Allergies",
          "type": "string"
        }
      ]
    },
    {
      "subheading": "Insurance Information",
      "fields": [
        {
          "name": "Member ID #",
          "type": "string"
        },
        {
          "name": "Does patient have other coverage?",
          "type": "boolean",
          "conditional_on_value": true,
          "sub_fields": [
            {
              "name": "Group #",
              "type": "string"
            },
            {
              "name": "If yes, provide ID#",
              "type": "string"
            },
            {
              "name": "Carrier Name",
              "type": "string"
            },
            {
              "name": "Insured",
              "type": "string"
            }
          ]
        }
      ]
    },
    {
      "subheading": "Prescriber Information",
      "fields": [
        {
          "name": "First Name",
          "type": "string"
        },
        {
          "name": "Last Name",
          "type": "string"
        },
        {
          "name": "Prescriber Type",
          "type": "radio_choice",
          "options": [
            "M.D.",
            "D.O.",
            "N.P.",
            "P.A."
          ]
        },
        {
          "name": "Address",
          "type": "string"
        },
        {
          "name": "City",
          "type": "string"
        },
        {
          "name": "State",
          "type": "string"
        },
        {
          "name": "ZIP",
          "type": "string"
        },
        {
          "name": "Phone",
          "type": "string"
        },
        {
          "name": "Fax",
          "type": "string"
        },
        {
          "name": "St Lic #",
          "type": "string"
        },
        {
          "name": "NPI #",
          "type": "string"
        },
        {
          "name": "DEA #",
          "type": "string"
        },
        {
          "name": "UPIN",
          "type": "string"
        },
        {
          "name": "Provider Email",
          "type": "string"
        },
        {
          "name": "Office Contact Name",
          "type": "string"
        },
        {
          "name": "Office Contact Phone",
          "type": "string"
        }
      ]
    },
    {
      "subheading": "Dispensing Provider/Administration Information",
      "fields": [
        {
          "name": "Place of Administration",
          "type": "multi_select",
          "options": [
            "Self-administered",
            "Physician's Office",
            "Home",
            "Outpatient Dialysis Center",
            "Outpatient Infusion Center",
            "Home Infusion Center"
          ]
        },
        {
          "name": "Agency Name (if applicable)",
          "type": "string"
        },
        {
          "name": "Administration code(s) (CPT)",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy Type",
          "type": "radio_choice",
          "options": [
            {
              "name": "Retail Pharmacy"
            },
            {
              "name": "Specialty Pharmacy"
            },
            {
              "name": "Mail Order"
            },
            {
              "name": "Other",
              "sub_fields": [
                {
                  "name": "Specify Other Dispensing Provider/Pharmacy Type",
                  "type": "string"
                }
              ]
            }
          ]
        },
        {
          "name": "Dispensing Provider/Pharmacy Name",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy Phone",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy Address",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy City",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy State",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy ZIP",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy Fax",
          "type": "string"
        },
        {
          "name": "TIN",
          "type": "string"
        },
        {
          "name": "PIN",
          "type": "string"
        },
        {
          "name": "NPI (Place of Administration)",
          "type": "string"
        },
        {
          "name": "NPI (Dispensing Provider/Pharmacy)",
          "type": "string"
        }
      ]
    },
    {
      "subheading": "Product Information",
      "fields": [
        {
          "name": "Request is for",
          "type": "multi_select",
          "options": [
            "Riabni (rituximab-arrx)",
            "Rituxan (rituximab)",
            "Ruxience (rituximab-pvvr)",
            "Truxima (rituximab-abbs)"
          ]
        },
        {
          "name": "Dose",
          "type": "string"
        },
        {
          "name": "Directions for Use",
          "type": "string"
        },
        {
          "name": "HCPCS Code",
          "type": "string"
        }
      ]
    },
    {
      "subheading": "Diagnosis Information",
      "fields": [
        {
          "name": "Primary ICD Code",
          "type": "string"
        },
        {
          "name": "Other ICD Code",
          "type": "string"
        }
      ]
    },
    {
      "subheading": "Clinical Information",
      "fields": [
        {
          "name": "Has the patient had prior therapy with the requested product within the last 365 days?",
          "type": "boolean"
        },
        {
          "name": "Has the patient had a trial and failure of any of the following rituximab biosimilars?",
          "type": "multi_select_with_conditional",
          "options": [
            "No",
            "Ruxience (rituximab-pvvr)",
            "Truxima (rituximab-abbs)"
          ],
          "conditional_on_option_not_selected": "No",
          "sub_fields": [
            {
              "name": "When was the member's trial and failure of the preferred drug?",
              "type": "string"
            },
            {
              "name": "Please describe the nature of the failure of the preferred drug",
              "type": "string"
            }
          ]
        },
        {
          "name": "Has the patient had an adverse reaction to any of the following rituximab biosimilars?",
          "type": "multi_select_with_conditional",
          "options": [
            "No",
            "Ruxience (rituximab-pvvr)",
            "Truxima (rituximab-abbs)"
          ],
          "conditional_on_option_not_selected": "No",
          "sub_fields": [
            {
              "name": "When was the member's adverse reaction to the preferred drug?",
              "type": "string"
            },
            {
              "name": "Please describe the nature of the adverse reaction to the preferred drug",
              "type": "string"
            }
          ]
        },
        {
          "name": "Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when indicated for the patient's diagnosis?",
          "type": "multi_select",
          "options": [
            "Ruxience (rituximab-pvvr)",
            "Truxima (rituximab-abbs)"
          ]
        },
        {
          "name": "Has the patient had a trial and failure of any of the following (MA plans)?",
          "type": "multi_select_with_conditional",
          "options": [
            "No",
            "Inflectra (infliximab-dyyb)",
            "Renflexis (infliximab-abda)",
            "Simponi Aria (golimumab)"
          ],
          "conditional_on_option_not_selected": "No",
          "sub_fields": [
            {
              "name": "When was the member's trial and failure of the preferred drug?",
              "type": "string"
            },
            {
              "name": "Please describe the nature of the failure of the preferred drug",
              "type": "string"
            }
          ]
        },
        {
          "name": "Has the patient had an adverse reaction to any of the following (MA plans)?",
          "type": "multi_select_with_conditional",
          "options": [
            "No",
            "Inflectra (infliximab-dyyb)",
            "Renflexis (infliximab-abda)",
            "Simponi Aria (golimumab)"
          ],
          "conditional_on_option_not_selected": "No",
          "sub_fields": [
            {
              "name": "When was the member's adverse reaction to the preferred drug?",
              "type": "string"
            },
            {
              "name": "Please describe the nature of the adverse reaction to the preferred drug",
              "type": "string"
            }
          ]
        },
        {
          "name": "Has the patient had a trial and failure of any of the following (MAPD plans)?",
          "type": "multi_select_with_conditional",
          "options": [
            "No",
            "Enbrel (etanercept)",
            "Humira (adalimumab)",
            "Idacio (adalimumab-aacf)",
            "Rinvoq (upadacitinib)",
            "Tyenne SC (tocilizumab-aazg)",
            "Xeljanz/Xeljanz XR (tofacitinib)"
          ],
          "conditional_on_option_not_selected": "No",
          "sub_fields": [
            {
              "name": "When was the member's trial and failure of the preferred drug?",
              "type": "string"
            },
            {
              "name": "Please describe the nature of the failure of the preferred drug",
              "type": "string"
            }
          ]
        },
        {
          "name": "Has the patient had an adverse reaction to any of the following (MAPD plans)?",
          "type": "multi_select_with_conditional",
          "options": [
            "No",
            "Enbrel (etanercept)",
            "Humira (adalimumab)",
            "Idacio (adalimumab-aacf)",
            "Rinvoq (upadacitinib)",
            "Tyenne SC (tocilizumab-aazg)",
            "Xeljanz/Xeljanz XR (tofacitinib)"
          ],
          "conditional_on_option_not_selected": "No",
          "sub_fields": [
            {
              "name": "When was the member's adverse reaction to the preferred drug?",
              "type": "string"
            },
            {
              "name": "Please describe the nature of the adverse reaction to the preferred drug",
              "type": "string"
            }
          ]
        },
        {
          "name": "Contraindications or other medical reasons patient cannot use preferred MA plan products?",
          "type": "multi_select",
          "options": [
            "Inflectra (infliximab-dyyb)",
            "Renflexis (infliximab-abda)",
            "Simponi Aria (golimumab)"
          ]
        },
        {
          "name": "Contraindications or other medical reasons patient cannot use preferred MAPD plan products?",
          "type": "multi_select",
          "options": [
            "Enbrel (etanercept)",
            "Humira (adalimumab)",
            "Idacio (adalimumab-aacf)",
            "Rinvoq (upadacitinib)",
            "Tyenne SC (tocilizumab-aazg)",
            "Xeljanz/Xeljanz XR (tofacitinib)"
          ]
        },
        {
          "name": "Will Rituxan (rituximab) be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs (e.g., adalimumab, infliximab)?",
          "type": "boolean"
        },
        {
          "subheading": "Acute lymphoid leukemia",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?",
              "type": "boolean"
            },
            {
              "name": "Is Rituxan (rituximab) being used as induction/consolidation therapy?",
              "type": "boolean"
            }
          ]
        },
        {
          "subheading": "Autoimmune hemolytic anemia",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of refractory autoimmune hemolytic anemia?",
              "type": "boolean"
            }
          ]
        },
        {
          "subheading": "Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides",
          "fields": [
            {
              "name": "Which of the following applies to the patient?",
              "type": "multi_select",
              "options": [
                "Wegener granulomatosis",
                "Churg-Strauss syndrome",
                "Microscopic polyangiitis",
                "pauci-immune glomerulonephritis"
              ]
            },
            {
              "name": "Will Rituxan (rituximab) be given in conjunction with glucocorticoids?",
              "type": "boolean"
            }
          ]
        },
        {
          "subheading": "Autoimmune blistering diseases, corticosteroid-refractory",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?",
              "type": "boolean"
            },
            {
              "name": "Which applies to the patient?",
              "type": "multi_select",
              "options": [
                "pemphigus vulgaris",
                "pemphigus folliaceus",
                "bullous pemphigoid",
                "cicatricial pemphigoid",
                "epidermolysis bullosa acquisita",
                "paraneoplastic pemphigus",
                "None of the above"
              ]
            }
          ]
        },
        {
          "subheading": "B-cell lymphomas",
          "fields": [
            {
              "name": "Which applies to the patient?",
              "type": "multi_select",
              "options": [
                "AIDS-related B-cell lymphoma",
                "Burkitt lymphoma",
                "Diffuse large B-cell lymphoma",
                "Follicular lymphoma",
                "Gastric MALT lymphoma",
                "High-grade B-Cell lymphoma",
                "Mantle cell lymphoma",
                "Nodal marginal zone lymphoma",
                "Nongastric MALT lymphoma",
                "Primary cutaneous B-cell lymphomas",
                "Splenic marginal zone lymphoma",
                "Other"
              ],
              "conditional_on_option": "Other",
              "sub_fields": [
                {
                  "name": "Specify Other B-cell lymphoma",
                  "type": "string"
                }
              ]
            }
          ]
        },
        {
          "subheading": "Castleman's disease",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of multicentric Castleman's disease (angiofollicular lymph node hyperplasia)?",
              "type": "boolean"
            }
          ]
        },
        {
          "subheading": "Central nervous system lymphomas",
          "fields": [
            {
              "name": "Which applies to the patient?",
              "type": "multi_select",
              "options": [
                "leptomeningeal metastases from lymphoma",
                "primary CNS lymphoma",
                "none of the above"
              ]
            }
          ]
        },
        {
          "subheading": "Chronic or small lymphocytic leukemia",
          "fields": [
            {
              "name": "Which applies to the patient?",
              "type": "multi_select",
              "options": [
                "chronic lymphocytic leukemia (CLL)",
                "small lymphocytic leukemia",
                "none of the above"
              ]
            }
          ]
        },
        {
          "subheading": "Cryoglobulinemia",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of cryoglobulinemia?",
              "type": "boolean"
            },
            {
              "name": "Is there clinical documentation that the treatment with corticosteroids and other immunosuppressive agents was ineffective?",
              "type": "boolean"
            }
          ]
        },
        {
          "subheading": "Graft versus host disease, chronic",
          "fields": [
            {
              "name": "Is there a documentation that Rituxan (rituximab) being used as last-resort treatment for chronic graft versus host disease (GVHD)?",
              "type": "boolean"
            }
          ]
        },
        {
          "subheading": "Hairy cell leukemia",
          "fields": [
            {
              "name": "Which applies to the patient?",
              "type": "multi_select",
              "options": [
                "relapsed hairy cell leukemia",
                "refractory hairy cell leukemia",
                "none of the above"
              ]
            }
          ]
        },
        {
          "subheading": "Heart and solid organ transplant",
          "fields": [
            {
              "name": "Is there a documentation that Rituxan (rituximab) is being used for treatment or prevention (desensitization) of highly sensitized patients with antibody mediated rejection in heart transplant recipients and other solid organ transplant recipients?",
              "type": "boolean"
            },
            {
              "name": "Which applies to the patient?",
              "type": "multi_select",
              "options": [
                "heart transplant recipient",
                "other solid organ transplant recipient"
              ]
            }
          ]
        },
        {
          "subheading": "Immune checkpoint-inhibitor related encephalitis",
          "fields": [
            {
              "name": "Which immune check-point inhibitor caused the encephalitis?",
              "type": "multi_select",
              "options": [
                "Bavencio (avelumab)",
                "Imfinzi (durvalumab)",
                "Keytruda (pembrolizumab)",
                "Opdivo (nivolumab)",
                "Tecentriq (atezolizumab)",
                "Yervoy (ipilimumab)",
                "Other"
              ],
              "conditional_on_option": "Other",
              "sub_fields": [
                {
                  "name": "Specify Other Immune checkpoint-inhibitor",
                  "type": "string"
                }
              ]
            }
          ]
        },
        {
          "subheading": "Immune or idiopathic thrombocytopenic purpura",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?",
              "type": "boolean",
              "conditional_on_value": true,
              "sub_fields": [
                {
                  "name": "If yes, please specify type",
                  "type": "radio_choice",
                  "options": [
                    "refractory immune thrombocytopenic purpura",
                    "idiopathic thrombocytopenic purpura (ITP)"
                  ]
                }
              ]
            }
          ]
        },
        {
          "subheading": "Kidney transplant, rejection prophylaxis",
          "fields": [
            {
              "name": "Is Rituxan (rituximab) being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies?",
              "type": "boolean"
            }
          ]
        },
        {
          "subheading": "Lymphocyte-predominant Hodgkin's lymphoma",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of lymphocyte-predominant Hodgkin's lymphoma?",
              "type": "boolean"
            }
          ]
        },
        {
          "subheading": "Multiple Sclerosis",
          "fields": [
            {
              "name": "Type of multiple sclerosis patient has been diagnosed with",
              "type": "multi_select",
              "options": [
                "Relapsing-remitting MS (RRMS)",
                "Secondary-progressive MS (SPMS)",
                "Primary-progressive MS (PPMS)",
                "Progressive-relapsing MS (PRMS)"
              ]
            },
            {
              "name": "Has the patient discontinued other medications used for treating MS (not including Ampyra)?",
              "type": "boolean"
            }
          ]
        },
        {
          "subheading": "Myasthenia gravis (MuSk-MG)",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)?",
              "type": "boolean"
            },
            {
              "name": "Has the patient had an unsatisfactory response to initial immunotherapy?",
              "type": "boolean"
            }
          ]
        },
        {
          "subheading": "Neuromyelitis optica (Devic's disease)",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of neuromyelitis optica (Devic's disease)?",
              "type": "boolean"
            },
            {
              "name": "Was the treatment with at least one immunotherapy ineffective?",
              "type": "boolean"
            }
          ]
        },
        {
          "subheading": "Opsoclonus-myoclonus-ataxia (opsoclonus myoclonus syndrome)",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma?",
              "type": "boolean"
            },
            {
              "name": "Is the patient refractory to steroids, chemotherapy and intravenous immunoglobulins?",
              "type": "boolean"
            },
            {
              "name": "Please provide the names and date ranges of medications tried",
              "type": "string"
            }
          ]
        },
        {
          "subheading": "Rheumatoid Arthritis",
          "fields": [
            {
              "name": "Severity of the patient's rheumatoid arthritis",
              "type": "radio_choice",
              "options": [
                "Mild",
                "Moderate",
                "Severe"
              ]
            },
            {
              "name": "Is there evidence that the disease is active?",
              "type": "boolean"
            },
            {
              "name": "Will Rituxan (rituximab) be used in combination with methotrexate?",
              "type": "boolean"
            },
            {
              "name": "Was treatment with methotrexate ineffective, not tolerated or contraindicated?",
              "type": "boolean",
              "conditional_on_value": true,
              "sub_fields": [
                {
                  "name": "Please select (Methotrexate reason)",
                  "type": "multi_select",
                  "options": [
                    "ineffective",
                    "not tolerated",
                    "contraindicated"
                  ]
                }
              ]
            },
            {
              "name": "Was treatment with another conventional DMARD ineffective?",
              "type": "boolean",
              "conditional_on_value": true,
              "sub_fields": [
                {
                  "name": "Please select (Conventional DMARDs)",
                  "type": "multi_select",
                  "options": [
                    "azathioprine",
                    "cyclosporine",
                    "hydroxychloroquine",
                    "leflunomide",
                    "sulfasalazine"
                  ]
                }
              ]
            }
          ]
        },
        {
          "subheading": "Sj\u00f6gren syndrome",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of Sj\u00f6gren's syndrome?",
              "type": "boolean"
            },
            {
              "name": "Was treatment with corticosteroids and other immunosuppressive agents ineffective?",
              "type": "boolean",
              "conditional_on_value": true,
              "sub_fields": [
                {
                  "name": "Please provide the names and dates of the corticosteroids and other immunosuppressive agents used",
                  "type": "array_of_objects",
                  "item_schema": {
                    "Medication": {
                      "type": "string"
                    },
                    "Dates": {
                      "type": "string",
                      "format": "MM/DD/YYYY"
                    }
                  },
                  "min_items": 1,
                  "max_items": 2
                }
              ]
            }
          ]
        },
        {
          "subheading": "Thrombotic thrombocytopenic purpura",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)?",
              "type": "boolean"
            }
          ]
        },
        {
          "subheading": "Waldenstrom's macroglobulinemia",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of Waldenstr\u00f6m macroglobulinemia?",
              "type": "boolean"
            }
          ]
        }
      ]
    },
    {
      "subheading": "Continuation Request Information",
      "fields": [
        {
          "name": "Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)?",
          "type": "boolean"
        },
        {
          "name": "Please indicate the length of time on Rituxan (rituximab)",
          "type": "string"
        }
      ]
    }
  ]
}